On the transplantation, regeneration and induction of bone: The path to bone morphogenetic proteins and other skeletal growth factors

Surgeon

Volumn 5, Issue 4, 2007, Pages 232-243

  Meikle, Murray C ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BMPs; Bone transplantation; Engineering bone in vivo; Sir William Macewen

Indexed keywords

EID: 34547811450     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(07)80008-4     Document Type: Review

References (89)

1. Chase SW, Herndon CH. The fate of autogenous and homogenous bone grafts. A historical review. J Bone Joint Surg Am 1955; 37: 809-41
2. Duhamel HL. Sur le development et la crue des os des animaux. Mém de l'Acad Roy des Sci 1742; 354-70
3. Woodruff MW. The Transplantation of Tissues and Organs. Charles C Thomas: Springfield, Illinois; 1960
4. Bowman AK. The life and teaching of Sir William Macewen. In: The History of Surgery. William Hodge and Company Limited: London; 1942
5. Macewen W. Observations concerning transplantation of bone, illustrated by a case of interhuman osseous transplantation, whereby two-thirds of the shaft of a humerus was restored. Proc Roy Soc Lond 1881; 32: 232-47
6. Macewen W. The Growth of Bone. Observations on Osteogenesis. An Experimental Enquiry into the Development and Reproduction of Diaphyseal Bone. James Maclehose and Sons: Glasgow; 1912
7. Barth A. Histologische untersuchungen über knochenimplantationen. Beit pathol Anat 1895; 17: 65-142
8. Axhausen G. Histologische unterschungen über knochentransplantation am menschen. Deutsche Zeitschr für Chir 1907; 91: 388-428
9. Axbausen G. Die histologischen und Klinischen Gesetze der freien Osteoplastik auf Grund von Thierversuchen. Archiv für Klinik Chir 1909; 88: 23-145
10. Phemister DB. The fate of transplanted bone and the regenerative power of its various constituents. Surg Gynec Obstet 1914; 19: 303-33
11. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat 1943; 77: 299-310
12. Medawar PB. The behaviour and fate of skin autografts and skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research Council. J Anat 1944; 78: 176-99
13. Medawar PB. A second study of the behaviour and fate of skin homografts in rabbits: A report to the War Wounds Committee of the Medical Research Council. J Anat 1945; 79: 157-176.
14. Billingham RE, Brent L, Medawar PB. The antigenic stimulus in transplantation immunity. Nature 1956; 178: 514-19
15. Medawar PB. Reactions to homlogous tissue antigens in relation to hypersensitivity. In: Cellular and Humoral Aspects of the Hypersensitive States. Lawrence HS, ed. Paul B Hoeber Inc New York; 1959: 504-29
16. Bonfiglio M, Jeter WS, Smith CL, The immune concept: Its relation to bone transplantation. Ann N Y Acad Sci 1955; 59: 417-33
17. Curtis PH, Herndon CH. Immunological factors in homogenous bone transplantation. I. Serological studies. J Bone Joint Surg Am 1956: 38: 103-10
18. Burwell RG, Gowland G. Studies in the transplantation of bone. I. Assessment of antigenicity. Serological studies. J Bone Joint Surg 1961; 43B: 814-19
19. Enneking WF. Histological investigation of bone transplants in immunologically prepared animals, J Bone Joint Surg Am 1957; 39A: 597-615
20. Chalmers J. Transplantation immunity in bone bomografting. J Bone Joint Surg Br 1959; 41B: 160-79
21. Heslop BF, Zeiss IM, Nisbet NW. Studies on transference of bone. I. A comparison of autologous, and homologous bone implants with reference to osteocyte survival, osteogenesis and host reaction. Br J Exp Pathol 1960; 41: 269-87
22. Nisbet NW, Heslop BF, Zeiss IM. Studies on transference of bone. III. Manifestations of immunological tolerance to implants of homologous cortical bone in rats. Br J Exp Pathol 1960; 41: 443-51
23. Burwell RG, Gowland G. Studies in the transplantation of bone. II. The changes occurring in the lymphoid tissue after homografts and autografts of fresh cancellous bone. J Bone Joint Surg 1961; 43B: 820-43
24. Burwell RG. Studies in the transplantation of bone. V. The capacity of fresh and treated homografts of bone to evoke transplantation immunity. J Bone Joint Surg 1963; 45B: 386-401
25. Enneking WF, Gratch A. The effect of total body irradiation on bone transplantation in parabiosed animals. J Bone Joint Surg 1959; 41A: 463-75
26. Burwell RG, Gowland G, Dexter F. Studies in the transplantation of bone. VI. Further observations concerning the antigenicity of homologous cortical and cancellous bone. J Bone Joint Surg 1963; 45B: 597-608
27. Heiple KG, Chase SW, Herndon CH. A comparative study of the healing process following different types of bone transplantation. J Bone Joint Surg 1963; 45A: 1593-612
28. Freiberg RA, Ray RD. Studies of devitalized bone implants. Arch Surg 1964; 89: 417-27
29. Huggins CB. Influence of urinary tract mucosa on the experimental formation of bone. Proc Soc Exp Biol Med 1930; 27: 349-51
30. Huggins CB. The formation of bone under the influence of epithelium of the urinary tract. Arch Surg 1931; 22: 377-408
31. Spemann H. Über Korrelationen in die Entwicklung des Auges. Verhandl Anat Gesell 1901; 15: 61-79
32. Spemann H, Mangold H. Über Induktion von Embryonalanlagen durch Implantation artfrender Organisatoren, Wilhelm Roux' Archiv für Entwicklung der Organ 1924; 100: 599-638
33. Levander G. A study of bone regeneration. Surg Gynecol Obstet 1938; 67: 705-14
34. Lacroix P, Recent investigations on the growth of bone. Nature 1945; 156: 576
35. Lacroix P. Organizers and the growth of bone. J Bone Joint Surg 1947; 29A: 292-96
36. Heinen JH, Dabbs GH, Mason HA. The experimental production of ectopic cartilage and bone in the muscles of rabbits. J Bone Joint Surg 1949; 31A: 765-75
37. Goldhaber P. Preliminary observations on bone isografts within diffusion chambers. Proc Soc Exp Biol Med 1958; 98: 53-6
38. Goldhaber P. Osteogenic induction across Millipore filters in vivo. Science 1961; 133: 2065-67
39. Urist MR. Bone: Formation by autoinduction. Science 1965; 150: 893-9
40. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971, 50: 1392-406
41. Urist MR, Jurist JM, Dubuc FL, Strates BS. Quantitation of new bone formation in intramuscular implants of bone matrix in rabbits. Clin Orthop Rel Res 1970; 68: 279-93
42. Urist MR, Iwata H, Coccotti PL, Dorfman RL, Boyd SD, McDowell RM, Chien C, et al. Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci USA 1973; 70: 3511-5
43. Urist MR, Lietze A, Mizutani H, Takegi K, Triffitt JT, Amstutz J, et al. A bovine low molecular weight bone morphogenetic protein (BMP) fraction. Clin Orthop Relat Res 1982; 162: 219-32
44. Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J, Lietze A, et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A 1984; 81: 371-5
45. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 1981; 78: 7599-603
46. Sampath TK, Muthukumaran N, Reddi AH. Isolation of osteogenin, an extracellular matrix-associated bone-inductive protein by heparin affinity chromatography. Proc Nat Acad Sci U S A 1987; 84, 7109-13
47. Luyten FP, Cunningham NS, Ma S, Muthukumaran N, Hammonds RG, Nevins WB, et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 1989; 264: 13377-80
48. Reddi AH, Muthukumaran N, Ma S, Carrington JL, Luyton FP, Paralkar VM, et al. Initiation of bone development by osteogenin and promotion by growth factors. Connect Tissue Res 1989; 20: 303-12
49. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, et al. Purification and characterization of other distinct bone-inducing factors. Proc Nat Acad Sci USA 1988; 85: 9484-8
50. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters, MJ, Kriz RW, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988; 242: 1528-34
51. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM, et al. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Nad Acad Sci U S A 1990; 87: 9843-7
52. Takao M, Hino J, Takeshita N, Konno Y, Nishizawa T, Matsuo H, Kangawa, et al. Identificotion of rat bone morphogenetic protein-3b (BMP-3b), a new member of BMP-3. Biochem Biophys Res Commun 1996; 219: 656-62
53. Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nature Genet 2001; 27: 84-8
54. Bahamonde ME, Tyler KM, BMP3: To be or not to be a BMP? J Bone Joint Surg Am 2001; 83A (Supplement 1): 56-62
55. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene,fiamily in bone formation and repair. Clin Orthop Relat Res 1998; 346: 26-37
56. Demers C, Hamdy RC. Bone morphogenetic proteins. Science and Medicine 1999; 6: 8-17
57. Yamaguchi A, Katagari T, Ikeda T, Wozney JM, Rosen V, Wang EA, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991; 113: 681-7
58. Gimble JM, Morgan C, Kelly K, Wu X, Dandapani V, Wang CS, Rosen V. Bone morphogenetic proteins inhibit adipocyte differentiation by marrow stromal cells. J Cell Biochem 1995; 58: 393-402
59. Chang SC, Hoang B, Thomas JT, Vukicevic S, Luyten FP, Ryba NJ, et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-β superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 1994; 269: 28227-34
60. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. Limb alterations in brachypodism mice due to mutations in a new member of the TGVβ-superfamily. Nature 1994; 368: 639-43
61. Centrella M, Canalis E. Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. Proc Natl Acad Sci U S A 1985; 82: 7335-9
62. Seyedin SM, Thompson AY, Bentz H, Rosen DM, McPherson JM, Conti A, et al. Cartilage-inducing factor-A. Apparent identity to transforming growth factor-β. J Biol Chem 1986; 261: 5693-5
63. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M, Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparinsepharose. J Biol Chem 1986; 261: 12665-74
64. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7
65. Mohan S, Jennings JC, Linkhart TA, Baylink DJ. Primary structure of human skeletal growth factor: Homology with human insulin-like growth factor-II. Biochim Biophys Acta 1988; 966: 44-55
66. Frolik CA, Ellis LF, Williams DC. Isolation and characterization of insulin-like growth factor-II from human bone. Biochem Biophys Res Comm 1988; 151: 1011-8
67. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54
68. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-64
69. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29
70. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-8
71. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 2004; 25: 581-611
72. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-28
73. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentialion: Auto-paracrine role during endochondral bone formation. J Cell Sci 2000; 113: 59-69
74. Tombran-Tink J, Barnstable CJ. Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: Possible mediators of angiogenesis and matrix remodeling in the bone. Biochem Biophys Res Commun 2004; 316: 573-9
75. Silber JS, Anderson DG, Daffner SD, Brislin BT, LeLand SM, Hilibrand HS, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003; 28: 134-9
76. Epidemiologic notes and reports transmission of HIV through bone transplantation: Case report and public health recommendations. Centre for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR) 1988; 37: 597-9
77. Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley W, et al. Transmission of human immunodeficiency virus type I from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-32
78. Li CM, Ho YR, Liu YC. Transmission of human immunodeficiency virus through bone transplantation: A case report. J Formos Med Assoc 2001; 100: 350-1
79. Reddi AH. Bone morphogenetic proteins: From basic science to clinical application. J Bone Joint Surg Am 2001; 83A: 1-6
80. Granjeiro JM, Oliveira RC, Bustos-Valenzuela JC, Sogayar MC, Taga R. Bone morphogenetic proteins: From structure to clinical use. Braz J Med Biol Res 2005; 38: 1463-73
81. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005; 16: 329-45
82. Coombes AGA, Meikle MC. Resorbable synthetic polymers as replacements for bone graft. Clinical Materials 1994; 17: 35-67
83. Schakenraad JM, Nieuwenhuis P, Molenaar I, Heider J, Dijkstra PJ, Feijen J. In vivo and in vitro degradation of glysine/DL-lactic acid copolymers. J Biomed Mater Res 1989; 23: 1271-88
84. Miyamoto S, Takaoka K, Okada T, Yoshikawa H, Hashimoto J, Suzuki S, Ono K. Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin Orthop Rel Res 1992; 278: 274-95
85. Meikle MC, Papaiaoannou S, Ratledge TJ, Speight PM, Watt-Smith SR, Hill PA, Reynolds JJ. Effect of poly DL-lactide-co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. Biomaterials 1994; 15: 513-21
86. Bonfield TL, Colton E, Marchant RE, Anderson JM. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J Biomed Mat Res 1992; 26: 837-50
87. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic, protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions: A prospective, randomized clinical trial comparing rhOP-1 with fresh bone autograft. J Bone Joint Surg Am 2001; 83A: Sl51-8
88. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg 2002; 84A: 2123-34
89. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial 2002 Volvo Award in clinical studies. Spine 2002; 27: 2662-73